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Abstract
Cytoskeleton-associated proteins play key roles not only in regulating cell morphology and
migration but also in proliferation. Mutations in the cytoskeleton-associated gene filamin A (FlnA)
cause the human disorder periventricular heterotopia (PH). PH is a disorder of neural stem cell
development that is characterized by disruption of progenitors along the ventricular epithelium
and subsequent formation of ectopic neuronal nodules. FlnA-dependent regulation of cytoskeletal
dynamics is thought to direct neural progenitor migration and proliferation. Here we show that
embryonic FlnA null mice exhibited a reduction in brain size, and decline in neural progenitor
numbers over time. The drop in the progenitor population was not attributable to cell death or
changes in premature differentiation, but to prolonged cell cycle duration. Suppression of FlnA led
to prolongation of the entire cell cycle length, principally in M-phase. FlnA loss impaired
degradation of cyclin b1-related proteins, thereby delaying the onset and progression through
mitosis. We found that the cdk1 kinase Wee1 bound FlnA, demonstrated increased expression
levels after loss of FlnA function, and was associated with increased phosphorylation of cdk1.
Phosphorylation of cdk1 inhibited activation of the anaphase promoting complex degradation
system, which was responsible for cyclin b1 degradation and progression through mitosis.
Collectively, our results demonstrate a molecular mechanism whereby FlnA loss impaired G2 to
M phase entry, leading to cell cycle prolongation, compromised neural progenitor proliferation,
and reduced brain size.
Introduction
Neural progenitor proliferation and brain size are principally modulated by two major cell
parameters, cell cycle length and early differentiation (Kintner, 2002; Cremisi et al., 2003;
Dehay and Kennedy, 2007; Farkas and Huttner, 2008). In mouse brain, corticogenesis
begins at E11 and ends at E18 (Takahashi et al., 1995). During this period, neuroepithelial
progenitors in the ventricular zone go through approximately 11 cell cycles, and in each
cycle, a fraction of the progenitor population will differentiate into intermediate progenitors
(referred to as basal progenitors) or directly exit the cell cycle to become post-mitotic
neurons (Takahashi et al., 1996). Therefore, an increase in pre-mature neural progenitor
differentiation can compromise the expansion of the neural progenitor pool, resulting in
impaired neurogenesis, and subsequently microcephaly (Miyata et al.; Cremisi et al., 2003).
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Conversely, cell cycle length can also impact the size of the progenitor pool (Miyata et al.;
Ohnuma and Harris, 2003). A prolonged cell cycle would proportionally inhibit the
generation of both progenitors and neurons over a defined period of time, yielding fewer
cortical neurons (Ohnuma and Harris, 2003). The precise interplay between cell cycle rate
and the differentiating fraction of neural progenitors will direct neural progenitor
proliferation, and finally determine brain size.
Neural progenitor progression through the various stages of the cell cycle (G1, Synthesis
(S), G2 and Mitosis (M) phases, with postmitotic neurons exiting the cell cycle at G0) are
mediated by cdk kinases and their activators, cyclin-related proteins (Murray and Kirschner,
1989; Leise and Mueller, 2002). For example, the cdk1/cyclinb1 complex is inactive prior to
entry into M phase owing to Wee1/Pkmyt1 kinase-regulated cdk1 phosphorylation (Gould
and Nurse, 1989). To enter M phase, progenitor cells activate cdk1/cyclinb1 through cdk1
dephosphorylation in part through degradation of Wee1-like kinases (Watanabe et al., 2004;
Okamoto and Sagata, 2007). M phase progression is further enhanced by the cdc25c
phosphatase (Lew and Kornbluth, 1996). Cdk1 activation also enhances cyclinb1
degradation through activation of the anaphase promoting complex (APC) system, involving
cdh1 and cdc20 (Rudner and Murray, 2000; Golan et al., 2002). As cells proceed into
metaphase, APC-regulated cyclinb1 degradation begins to inhibit cdk1 activation
(dephosphorylation) (Visintin et al., 1997). In an analogous fashion, cdk inhibitors, such as
the Cdk inhibitor p16, inhibit cdk4/6 interactions with cyclin d, thereby blocking the G1-S
phase transition and possible exit from the cell cycle. Disruption of the cyclins, cdk kinases,
or components of the APC system can delay progression through the various cell cycle
stages.
During human cortical development, mutations in the FLNA gene cause a malformation of
cortical development, periventricular heterotopia (PH) (Fox et al., 1998; Sheen et al., 2005).
PH is characterized by a disruption of neural progenitors along the ventricular
neuroepithelium, leading to ectopic neuronal nodules along the lateral ventricles and
reduced brain size. Cytoskeleton-related genes have been found to play a crucial role in
controlling brain size (bond et al., 1996). However, the underlying molecular mechanism
whereby FLNA regulates neural progenitor development, giving rise to these
neuropathological phenotypes is not known.
Materials and Methods
Mice
The Dilp2 mouse strain was obtained from the Comparative and Developmental Genetics
Dept. MRC Human Genetics Unit, Edinburgh EH4 2XU, UK. The Dilp2 strain has been
submitted to the European Mouse Mutant Archive (http://www.emmanet.org/) strain number
EM: 00387 (Hart et al., 2006). The Dilp2 mouse strain is C3H/HeN background and Dilp2
embryos usually die before E15.5. To prolong the survival period of FlnA-null embryos, we
crossbred Dilp2 female mice with wild-type (WT) S129/Sv male mice, which permitted us
to observe FlnA function at later ages. In the current work, we only characterized FlnA
effect on brain development until E18 due to the limits on the survival period of FlnA-null
embryos. FlnA function on progenitor proliferation might also influence neurogenesis after
this time period of normal corticogenesis.
All mouse studies were performed under approval from the Institutional Animal Care and
Use Committees of Harvard Medical School, Beth Israel Deaconess Medical Center, and
Albany Medical College in accordance with The National Institutes of Health Guide for the
Care and Use of Laboratory Animals.
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BrdU labeling in vivo
BrdU (Roche) was dissolved in sterile PBS at a concentration of 6 mg/ml. BrdU injection
was performed as previously described (Ferland et al., 2009). Briefly, for cumulative Brdu
labeling, E14 pregnant mice were injected intra-peritoneally with BrdU (60mg/kg body
weight) at 3-h intervals and sacrificed at varied time points, 2, 3, 6, 9 and 14 h; for mitotic
index labeling. Other E14 pregnant mice were injected once with Brdu and scarified at 1.5-
and 2-h intervals. For analysis of proliferation and differentiation, E14.5 and E17 pregnant
mice were injected once intra-peritoneally with BrdU (100mg/kg) and were sacrificed after a
24-h interval. For S-phase cell labeling, E15.5 pregnant mice were pulse-labeled with BrdU
for 20 min. All the embryos were removed and fixed in 4% paraformaldehyde and processed
for BrdU immunohistochemistry as previously described (Ferland et al., 2009). Prior reports
have suggested that BrdU may be cytotoxic and potentially affect mitogenesis, especially
when administered at very high doses. However, under our experimental conditions, we did
not observe the toxic effect of BrdU on cell growth, as seen by TUNEL staining (figure 2).
In addition, the in vitro assays were performed without Brdu labeling and also indicate that
FlnA loss prolongs the duration of M phase in FlnA-null cells.
Cell culture
Neuronal progenitors were isolated from the E13.5 mouse embryo cortex as previously
described (Sheen et al., 2006). Briefly, for neural progenitor isolation, E13.5 embryo
cortices were miscroscopically dissected to separate the telencephalon from the basal
ganglia. The tissue was triturated in Hanks balanced salt solution (HBSS) buffer, digested at
37°C in Earle's balanced salt solution (EBSS) containing papain (20 units/ml; Worthington
Biochemical) for 10-20 min. The undigested tissue chunks were allowed to settle for 2-5
min, and the suspended cells were filtered through a cell strainer (BD Falcon). Dissociated
cells were then re-suspended in knockout DMEM/F12 medium, a neural progenitor culture
medium (Invitrogen). For neural sphere growth, the cells were cultured in suspension in
tissue culture flasks (BD Falcon, Cat. No: 353108). M2 and A7 cell lines (a gift from Dr. T.
Stossel) were cultured in minimum essential MEM medium supplemented with 2% FBS, 8%
newborn calf serum and 1% penicillin-streptomycin. In addition, G418 (final concentration
500 μg/ml) was added to A7 cell culture medium to maintain FLNA expression
(Cunningham et al., 1992).
For the assays involving cell proliferation or drug administration, the cells were plated on
5-10 μg/cm2 laminin I (Trevigen, Cat. 3400-010-01)-coated 6-cm dishes at a density of
5×104 cells/cm2. Neural progenitor doubling time was calculated by cell count. For flow
cytometric analysis, neural progenitors were pulse-labeled with BrdU (10 μM) for 40 min,
and then washed twice with HBSS and continued to culture in neural progenitor medium for
varied time points. Cells were digested with trypsin, centrifuged, re-suspended in HBSS and
then fixed with 4% PFA. For examination of cell cycle progression from G2/M to G1 phase,
cultured neural progenitors were synchronized at G2/M phase by a treatment of 40 ng/ml
nocodazole (Cat. M1404, Sigma Aldrich) for 12-16 h, and then released to continue cell
cycle progression. At varied time points, cells were digested and fixed for flow cytometry or
western blot. For protein degradation studies, cultured neural progenitors were harvested for
western blot analyses after incubation in 100μM cycloheximide (Cat. C1988, Sigma
Aldrich) for varying lengths of time.
Flow cytometry—For BrdU-labeled neural progenitors, cell staining was performed
according to manufacturer's protocols with minor modifications (FITC BrdU Flow Kit, cat.
559619, BD Pharmingen, San Diego). Briefly, PFA-fixed cells were treated with DNase I to
expose BrdU epitopes and incubated with anti-BrdU antibody (1:100, Calbiochem, cat.
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NA61) and Alexa fluor 488 secondary antibody (1:300); total DNA was stained with 7-
AAD. The flow cytometry experiments were performed using a LASER SORP LSRII.
For propidium iodide (PI) staining, cells were re-suspended in HBSS and fixed by gently
dropping into cold 100% ethanol (-20 °C). The cells were centrifuged and re-suspended in
0.5ml of DNA staining solution (50 ug/ml PI and 0.5 mg/ml RNAse A in PBS). FACS
analysis was performed using a LASER SORP LSRII.
Tissue and cell processing for immunohistochemistry and
immunocytochemistry—Timed murine embryos (E14.5, E15.5, and E18) were
harvested from pregnant dams according to IACUC guidelines. Processing of tissue for
preparation of frozen and paraffin sections and routine histological staining was performed
according to previously described procedures (Ferland et al., 2006; Ferland et al., 2009). For
immunohistochemistry, sections were blocked in PBS containing 5% donkey serum, and
then incubated overnight using the appropriate primary antibodies. For FlnA staining,
paraffin sections were stained by rabbit anti-FLNA monoclonal antibody (1:300, Epitomics,
cat. 2242-1). For BrdU staining, tissue sections were retrieved by heating at 95-100°C in
citrate buffer for 15-20 min, and then quickly put into ambient distilled water to denature the
DNA, or alternate sections were slowly cooled and treated with DNAse I to cleave
chromosomal DNA. The following antibodies with corresponding dilutions were used for
the studies: mouse anti-BrdU (1:100, Calbiochem) and rat anti-BrdU (1:150, Serotec, cat.
MCA2060), rabbit anti-Ki-67 monoclonal antibody (1:200, Epitomics, cat. 4203-1), rabbit
anti-PH3 polyclonal antibody (1:250, Millipore cat: 06-570), rabbit anti-Sox2 (1:250,
Epitomics, cat. 2683-1), mouse anti-Reelin (1:50, Developmental Studies Hybridoma bank,
cat. R4B), mouse anti-CSPG (1:200, Sigma Aldrich cat. c8035), rabbit anti-Tbr-1 and anti-
Tbr-2 (1:150, Abcam, cat. ab31940, ab23345), mouse anti-actin (1:100, Santa Cruz,
sc-47778), mouse anti-beta-catenin and anti-N-cadherin (1:100, BD Biosciences, cat.
c19220 and 610920), mouse monoclonal antibody against phospho-FLNA (ser2152) (1:150)
were a kind gift from F. Nakamura (Stossel lab). Following incubation in primary antibody,
tissue sections were washed and treated with the appropriate secondary antibodies for two h.
The following secondary antibodies were used: dye 488 and dye 594 donkey anti-mouse
antibodies (1:200), and dye 488 and dye 594 donkey anti-rabbit antibodies (1:200) from
Jackson Immunoresearch. For F-actin staining, Alexa fluor 488 or rhodamine-labeled
phalloidin was used on frozen sections (dissolved in 1.5ml methanol, 1:50, Invitrogen cat.
A12379 and R415). Fluorescent microscopy images were obtained using the Olympus
AX70 microscope with a SNAP microphotographic system. Confocal images were obtained
using a Zeiss laser scanning microscope LSM 510.
For cellular staining of FlnA, Wee1, Pkmyt1, cdc25c and cyclinb1, cells were fixed using
ice-cold 10% (w/V) tri-chloroaectic acid (TCA) for 20 minutes, washed >3 times using PBS
and permeabilized by 0.2% triton-X100 (Yonemura et al., 2004). For other antibody
staining, cells were fixed by 4% PFA and permeabilized by triton-x100. Cell staining
procedure was the same as that used in tissue staining. The following antibodies were used
for cell staining: rabbit anti-FLNA (1:250, Epitomics, cat. 2242-1), mouse anti-FLNA
(1:100, Santa Cruz, cat. sc-58764), mouse and rabbit anti-Wee1 (1:50, Santa Cruz cat.
sc-5285 and sc-325), rabbit anti-Pkmyt1 (1:100, Epitomics cat. 3303-1), mouse anti-aurora b
(AIM-1, 1:100, BD Bioscience, cat. 611082), mouse and rabbit anti-cyclinb1 (1:100, Santa
Cruz cat. sc-245 and sc-752), mouse and rabbit anti-cdc25c (1:100, Santa Cruz cat. sc-55513
and sc-327). Secondary antibodies were the same as above for tissue staining.
Endogenous co-immunoprecipitation (co-IP) and western blot analyses—For
co-immunoprecipitation, neural progenitor cells were grown to 70-80% confluence on
laminin-coated dishes and synchronized by nocodazole treatment. Cells were lysed in a co-
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immunoprecipitation buffer (50mM Tris-HCl pH7.4, 150mM NaCl, 1% Triton-X-100, 1
mM Na3VO4, 2mM EDTA, 1mM PMSF, phosphatase inhibitor cocktail 3 (Sigma-Aldrich,
cat.p0044) and proteinase-inhibitor cocktail (Sigma-Aldrich cat. p8340)). Cell lysates were
centrifuged at 132,000 rpm for 15 min and the supernatants were incubated at 4°C with 8μg
of protein A/G beads-coupled anti-Wee1 (Santa Cruz, cat. sc-5285), cyclinb1 (Santa Cruz,
cat. sc-245), or anti-pan 14-3-3 (Santa Cruz, sc-629) antibodies for 3 h. The beads were
centrifuged at 3000 rpm for 1 min and washed with co-IP buffer for 3 times. Beads were
boiled in SDS-PAGE sample loading buffer for western blot. For co-IP, A7 melanoma cells
were cultured to 70-80% confluence and then synchronized by nocodazole treatment. Cells
were lysed as above and the supernatants were incubated with protein A/G beads-coupled
anti-FLNA (Santa Cruz, cat. sc-58764), anti-Wee1, or anti-pan 14-3-3 antibodies.
For western blot experiments, protein samples were loaded onto 8-12% SDS-PAGE gels for
electrophoresis, and transferred onto PVDF membrane (Bio-rad, cat.162-0177). Membranes
were incubated with primary antibodies overnight at 4°C, and with HRP-conjugated
secondary antibodies (1:3000, Jackson Immunoresearch) for 2 hours. Signals were detected
using LumiGOLD ECL detection kit (Signagen Laboratories, cat. SL100309). The following
primary antibodies were used: α-tubulin (1:2000, Santa Cruz, cat. 32293), integrin β1
(1:1000, BD Bioscience, cat.610467), FLNA (1:10000, Epitomics cat. 2242-1), FLNA
(1:1000, Santa Cruz cat. sc-58764), PH3 (1:2000, same as immunostaining), cdc20 (1:500,
Santa Cruz, cat. sc-8385 and sc-13162), cdh1 (1:500, Santa Cruz, cat. sc-56312), cyclinb1
(1:500, same as above), cdk1(1:1000, Calbiochem, pc25), phospho-cdk1 (pY-15) (1:500,
BD Biosciences cat.612306), Wee1 (1:500, same as above), cdc25c (1:500, Santa Cruz, cat.
sc-327 and sc-55513), cdc25c (1:500, Epitomics, cat.1302), and Pkymt1 (1:1000, Epitomics,
cat.3303).
Pull-down assay—FLNA c-terminal (aa2167-aa2647, protein code: P21333 on NCBI
website) was inserted into the prokaryotic expression vector pGEX-6p-3 through restriction
enzymatic digestion. GST-FLNA-C protein was expressed in BL21 bacteria and purified
through GSH-Sepharose 4B beads (GE Healthcare, cat. 17-0756-01). Endogenous Wee1
was pulled-down through incubation of purified GST-FLNA-C with A7 cell supernatants.
TUNEL staining—Cell death was detected by TUNEL staining (In situ cell death
detection kit, Roche cat. 12156792910). The procedures followed the manufacturer's
protocol.
Quantitative analysis—To quantify the number of positively labeled cells on serial tissue
sections, cell number was quantified using ImageJ software (NIH). Three coronal sections of
one FlnA-null brain were compared to 3 homotopic sections of one FlnA-WT brain in a
same litter. A total of more than 4 sets of experimental and control E18 embryonic brains
were used for analyses (i.e. ≥4 FlnA-WT brains and ≥4 FlnA–null brains), and 3 sets for
E15.5 embryo brains. Data are represented as the mean (n≥4 for E18 and =3 for E15.5) ±
STDEV for BrdU, Ki-67, PH3, Tbr-1, Tbr-2 and Sox2. P value was calculated by Excel
software. Significance was determined using a paired Student's T-test.
Cortex thickness was measured from digitized images using imaging software (Adobe
Photoshop). The thickness of FlnA-null brain cortex was reported as a relative value to that
of FlnA-WT brain cortex. Mean values, STDEV and T-test (p value) were calculated by
Excel software.
To quantify western blot results, the band intensity for a given sample was digitized, and
quantified using ImageJ (NIH) software. Greater than 3 replicates were performed for each
set of experiments. For temporal studies, the intensity of bands at time zero was arbitrarily
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set as 100, and the intensity value of other bands at other time points is reported as a relative
value to that the zero time point measurement.
Results
Loss of FlnA function leads to microcephaly in embryonic mice
While FlnA has been proposed to affect corticogenesis, the underlying pathological
mechanisms have not been explored. We therefore characterized the embryonic
development of C3H/HeN X S129/SV Dilp2 mice. These mutant mice harbor a T to A point
mutation in the FlnA gene, leading to a stop codon in exon 46, nonsense-mediated decay of
the FlnA mRNA, and undetectable FlnA protein levels using either N- (domain 4) or C-
terminal (last domain) FlnA antibodies (data available when required), consistent with prior
reports(Hart et al., 2006) The FlnAy/- embryos displayed a smaller physical body size
compared to age-matched WT controls (Fig. 1a), developed midline omphalocoeles, and
were embryonic lethal after E18. FlnAy/- brain size was also reduced both in the rostral-
caudal extent and in the width of the telencephalon (Fig. 1b), and the cortex was
significantly thinned at E15.5 (9% reduction) and E18 (15% reduction) compared to FlnAy/+
brain (Fig. 1c, 1d). At higher magnification, loss of cortical width was most prominent in
the cortical plate (Fig. 1d). FlnA was highly expressed in the ventricular (VZ) and
subventricular (SVZ) zones of the cerebral cortex, regions populated by proliferating neural
progenitors during mid-gestation (Fig. 1e), whereas FlnA expression was reduced in the
upper cortical layers, where post-migratory neurons were situated. The phenotype of smaller
brains and loss of cortical width in FlnAy/- embryos, as well as prominent FlnA expression
along the VZ/SVZ, suggested that FlnA might play a functional role in regulating progenitor
pool size during cortical development.
Decreased neural progenitor pool size in embryonic FlnAy/- mice
To address whether the reduction in brain size was due to altered progenitor development,
we used markers for cell proliferation as surrogates for determining the progenitor pool size
(Figs. 2 and 3). The Ki-67 antigen labels all cells in the cell cycle (G1, S, G2 and M
phases), but not those exiting the cycle, such as differentiated progenitors and newly born
neurons. The number of Ki-67-positive neural progenitors was significantly decreased by
28.2% and 13.4% in E18 (Fig. 2) and E15.5 (Fig. 3) FlnAy/- cortices, respectively,
compared to WT controls (n>3, **= p < 0.01, ***= p < 0.001). Moreover, fewer Ki67+
progenitors were seen both in the VZ as well as the intermediate zone (IZ) where secondary
progenitors reside. We similarly observed a decline in progenitor numbers along the
ventricular lining, as evidenced by phospho-histone H3 (PH3) staining, an M-phase marker.
The E18 (Fig. 2) and E15.5 (Fig. 3) FlnAy/- cortices showed a 25% and 9.2% decline,
respectively, in the number of PH3+ progenitors compared to WT controls (n>3, *= p <
0.05, ***= p < 0.001). Furthermore, pulsing with the thymidine analog, BrdU, captured
progenitors entering S-phase. Loss of FlnA resulted in a 31% and 15% decrease in the BrdU
+ cell number, respectively, in E18 and E15.5 cortices 24 h after BrdU pulse labeling (n>3,
**= p < 0.01, ***= p < 0.001). Again, fewer progenitors were seen in both the VZ/SVZ and
IZ (white brackets). Lastly, the diminished brain size in the FlnAy/- mice was not the result
of increased cell death, as evidenced by the absence of any significant increase in TUNEL
staining in comparison of FlnAy/- to FlnAy/+ cortices of E18 and E15.5 brains. Summarily,
our data indicated that the reduction in brain size seen with loss of FlnA was, in part, due to
a decline in the progenitor pool.
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FlnA-dependent defects in progenitor pool size are not a result of an increased
differentiation of neural progenitors
During the development of the cerebral cortex, neural progenitors undergo both self-
duplication and neuronal differentiation. The balance between these processes regulates
neural progenitor's proliferation and brain size. To explore a possible role for FlnA in cell
fate specification, we first quantified the number of neural cells expressing several layer
specific markers relative to the number of Sox2+ progenitor cells in E15 and E18 FlnAy/-
and FlnAy/+ cortices. If early onset differentiation increased, earlier formed layers (subplate/
preplate, marginal zone or deep cortical layer neurons) would be expected to be increased in
width compared to later-formed superficial cortical layers, composed of later born neurons.
The reelin antigen labels Cajal-Retzius neurons in the marginal zone, whereas chondroitin
sulfate proteoglycan (CSPG) is found in subplate and intermediate neurons. A slight
decrease in the layer thickness for both early markers was seen in the FlnAy/- brain,
suggesting that FlnA loss might actually lead to a reduction in early differentiation of neural
progenitors (Fig. 4a). We next examined two additional layer markers: Tbr-2, a
differentiating intermediate progenitor marker, and Tbr-1, a marker of earlier born neurons
located in deeper layers of the cortical plate. The number of Tbr-2 positive cells relative to
the number of Sox2 positive progenitors was reduced by 4.2% in the FlnAy/- E18 cortex
compared to WT control (Fig. 4b, c and d). Likewise, the number of Tbr-1 positive cells
relative to the number of Sox2 positive progenitors was decreased by 5.5% in FlnAy/- cortex
compared to FlnAy/+ cortex. These results would further imply that loss of FlnA resulted in
a decrease in progenitor differentiation.
Another measure of proliferation versus differentiation can be made through dual labeling
studies using Ki-67 and BrdU (Fig. 4b, c and d). Pulsed injection of BrdU labels
progenitors undergoing cell division at a particular instance in time. Secondary labeling with
Ki-67 at 24h post BrdU injection captures a subset of BrdU+ cells that remain progenitors,
as opposed to the Ki-67- and BrdU+ cells that have exited the cell cycle and adopted post-
mitotic neuronal fates. We observed fewer BrdU+ progenitors situated above the ventricular
zone (brackets referring to the intermediate zone in Figs. 2, 3) in FlnAy/- cortex as compared
to FlnAy/+ cortex, suggestive of slower or delayed differentiation. Additionally, a greater
proportion of BrdU+ and Ki-67+ labeled cells were seen in the FlnAy/- mice (37% vs 34% in
FlnAy/- E18 brain; n>3, *= p < 0.05, **= p < 0.01), indicating again a decline in
differentiation. Finally, co-staining with Tuj1, a neuronal marker, revealed an increased
proportion of Tuj1 to Sox2 cells in the FlnAy/- cortices as compared to WT (data available
when required). These findings also indicated that early differentiation was not the cause of
the reduction in proliferation observed above in FlnAy/- mice. Similar, albeit less
pronounced changes were seen in the analysis of the E15.5 FlnAy/- cortex (data available
when required). Taken together, the decline in progenitor pool numbers, due to loss of FlnA,
was not derived from a premature-onset differentiation of neural progenitors.
Loss of FlnA prolongs cell cycle progression and delays G2/M to G1 phase transition
One possible mechanism that could account for the reduction in neural progenitor numbers
would be a role for FlnA in regulating the cell cycle. Given that phenotypic changes due to
loss of FlnA might not be apparent until later in development (i.e., E15.5 and E18), we
performed in vivo pulse BrdU labeling for 1.5 and 2h, and cumulative BrdU labeling for 2,
3, 9 and 14h in E14 embryos to analyze loss of FlnA effects on the cell cycle (Fig. 5). The
percentage of BrdU+ cells with respect to the total number of cells in the ventricular zone
(labeling index, LI; the maximal LI is 1 when all the cells are BrdU-positive) was quantified
by counting the number of BrdU+ cells in a defined region of mediodorsal frontal cortex.
Similar to the previously reported control data (Takahashi et al., 1993), LI in FlnAy/+
cortices was 0.42±0.01, 0.46±0.02, 0.85±0.015 and 0.97±0.01, respectively, for 2-, 3-, 9-,
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and 14-h cumulative BrdU labeling (Fig. 5). In contrast, LI in FlnAy/- cortex was
significantly reduced to 0.43±0.02, 0.75±0.025, respectively, for 3- and 9-h BrdU labeling,
but unchanged for 2- and 14-hour cumulative labeling (Fig. 5). A linear fit plot of LI as a
function of labeling time allowed for determination of the duration for each cell cycle phase.
By 14-h, the number of BrdU+ cells in either WT or mutant mouse had reached a maximal
plateau. From the plot, Tc (the whole cell cycle length) - Ts (S-phase length) corresponded to
the minimal time necessary to reach the maximal LI (10.8 h for FlnAy/+ cells versus 12.9 h
for FlnAy/- cells). Ts could be determined from the relative ratio of the LI for Ts versus Tc
(Ts/ Tc=0.28/GF). Thus, FlnA loss caused an increase of the whole cell cycle length Tc to
17.9 h vs 15.1 h in WT and an increase in S-phase length Ts to 5 h, (FlnAy/-) compared to
4.3 h in WT. TG2+M (the length of G2- and M-phases) was measured from the minimum
time required for all mitotic cells (PH3+) along the ventricular surface to become BrdU
labeled. After a 1.5 h interval, 74% and 68% of PH3+ cells were BrdU-labeled along the
FlnAy/+ and FlnAy/- ventricular surfaces, respectively (Fig. 5, BrdU/PH3 staining). By 2h,
the mitotic labeling index increased to 98±2% for FlnAy/+ cells and to 90±2% for FlnAy/-
cells. Therefore, for FlnAy/+ mitotic cells, the maximal LI was achieved within 2h (TG2+M
for WT), whereas the time interval for the maximal LI was interpolated to be 2.3 h (TG2+M)
for FlnAy/- mitotic cells, assuming a linear rate of LI ascent after 2 h. TG1 (G1 phase length)
could be calculated by TG1= Tc-Ts-TG2+M, and became 10.6 h in null FlnA mice, compared
to 8.8 h for WT mice. Finally, M phase length was estimated by Tc X the ratio of M-phase
cells to total cells in the ventricular zone (Fig. 5, PH3 staining). For FlnAy/+ PH3+ cells, the
ratio was 0.043±0.004, giving an M phase length of 40 min (TM =0.66 h). In contrast, the
ratio for FlnAy/- PH3+ cells was 0.063±0.005, and so M phase length was 66 min (TM =1.1
h). G2-phase length became 1.2 h in FlnAy/- mice as opposed to 1.34 h in WT mice. The
duration of each phase of the cell cycle (TC, TG1, TS, TG2+M, TG2 and TM phases) lengths is
summarized in Table 1. It is noteworthy that loss of FlnA affected every phase length in the
cell cycle with the most significant changes arising in M-phase and G1 phase lengths, with
66% and 20% increases, respectively. Therefore, loss of FlnA function led to a prolonged
cell cycle, resulting in an overall reduction in the number of progenitors generated.
The cell cycle analyses in vivo prompted us to further characterize FlnA function and
regulation of cell cycle in vitro. Consistent with the impaired proliferation seen in vivo, the
doubling time of cultured E13.5 FlnAy/- neural progenitors was prolonged by more than
25% compared to that of FlnAy/+ progenitors (12.7h for FlnAy/+ cells vs 16.9h for FlnAy/-
cells) (Fig. 6a,b). To better characterize the effects of FlnA suppression that was observed
on cell cycle transitions from S to G1 phase, we again pulse labeled progenitors with BrdU
for 40 min and used flow cytometry to examine progression through phases of the cell cycle
(Fig. 6c, 0h). Slower cell cycle progression from S-phase to G1 phase was seen in the
FlnAy/- progenitor population (see arrow in Fig. 6c). Given the above in vivo results (Table
1), we suspected that the slower S-G2/M-G1 phase transition of FlnAy/- progenitor might be
due to an M-phase delay. We therefore synchronized the neural progenitors to the G2/M
phase by nocodazole treatment and observed the cell cycle progression after nocodazole
release by flow cytometry (Fig. 6d). More than 40% FlnAy/+ progenitors passed through M-
phase to G1 phase within 1.5h, compared to less than 20% of the FlnAy/- progenitors (n>3,
p≤0.001). The cell cycle progression of FlnAy/- progenitors was still delayed after 8h (Fig.
6d). Overall, these findings indicated that the neural progenitor proliferation defects seen
following FlnA inhibition arose from a defect in cell cycle progression, principally from G2/
M to G1 phase transition and secondarily from G1 phase.
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FlnA regulates cyclinb1 degradation through cdk1 Tyr15 phosphorylation in neural
progenitors
To transition through the various phases of mitosis, neural progenitors entering metaphase
must first inactivate cdk1 (through phosphorylation of cdk1) to initiate degradation of
cyclinb1 through the APC system. Progression from metaphase to anaphase and anaphase to
G1 is regulated by activators of the APC, cdh1 and cdc20. To address whether FlnA
regulated cyclinb1 levels, we first examined the temporal course of cyclinb1 expression in
both FlnAy/+ and FlnAy/- progenitors after nocodozole synchronization (time zero
corresponding to G2/M entry phase). Cyclinb1 levels rapidly declined in FlnAy/+ cells as
mitosis progressed over a 180-min time period, but the decline was significantly slower in
the FlnAy/- cells (Fig. 7a). Both cdh1 and cdc20, which promoted cyclinb1 degradation
through the APC system, however, also underwent significantly slower rates of clearance in
the FlnAy/- progenitors compared to FlnAy/+ cells. To determine whether the slower rates of
decline in the levels of expression for these proteins in FlnAy/- progenitors were due to
impairments in protein degradation or increased protein synthesis, we examined the
expression levels of cyclinb1 and cdc20 after addition of the protein synthesis inhibitor,
cyclohexamide (Fig. 7b). Similar to the results from the nocodazole treatment studies, both
proteins exhibited increased expression levels in the FlnAy/- progenitors compared to WT
cells over time, indicating a disruption in the clearance of these cell cycle proteins. Cdc20
and cdh1 promote cyclinb1 degradation through the APC system. The expression levels of
these APC regulators were actually increased but not decreased in FlnAy/- neural progenitors
(Fig. 7c) suggesting that the impaired rate of cyclinb1 degradation was not attributable to
either of these proteins and more likely, another molecule in the APC system.
With cyclinb1, cdk1 phosphorylates several target substrates that promote activation of the
APC degradation system (Rudner and Murray, 2000; Golan et al., 2002). Cdk1 activation is
regulated by binding to cyclinb1 and also inhibited by cdk1 phosphorylation at tyrosine
(Tyr15). In FlnAy/- progenitors and FLNA-null M2 cells, we detected a significant (>3 fold)
increase in cdk1 phosphorylation at Tyr15 site (Fig. 7c), suggesting that a greater proportion
of cdk1 existed in the inactivated versus activated state in FlnA y/-- cells. Furthermore, cdk1
Tyr15 phosphorylation levels remained increased in FlnAy/- progenitors throughout the
entire period of mitosis after nocodozole release (Fig. 7d), whereas cdk1 phosphorylation in
FlnAy/+ progenitors abruptly decreased as mitosis progressed (Fig. 7d). Overall, these
observations indicated that FlnA regulated cyclinb1 degradation by affecting the status of
cdk1 Tyr15 phosphorylation in neural progenitors.
FlnA interacts with Wee1-like proteins in neural progenitors
To clarify the molecular mechanism by which FlnA regulated cdk1 inactivation via Tyr15
phosphorylation, we first addressed whether FlnA physically interacted with several
regulators of cdk1 activity. Wee1 is conserved among all eukaryotes and phosphorylates
Tyr15, whereas members of the cdc25 family are phosphatases, counteracting this activity.
We could not demonstrate binding of FlnA to cyclinb1 or cdc25c (Fig. 8a, b). Compared
with control co-immunoprecipitation, FlnA weakly interacted with the protein 14-3-3, a
regulator of Wee1, (Fig. 8c) but significantly bound to Wee1 endogenously in both neural
progenitors and FLNA-expressing A7 cells (Fig. 8d and e). We have previously observed
that the FlnA C-terminal fragment bound to several proline-rich proteins (unpublished data),
and Wee1 contain a proline-rich domain at the N-terminal. As expected, Wee1 was able to
bind the C-terminal portion of FLNA, further suggesting that the actin binding protein
interacted with Wee1 through the proline-rich region (Fig. 8f). Immunostaining showed
overlapping FlnA and Wee1 expression at the cell membrane and peri-nuclear region (Fig.
8g). FLNA appeared to regulate the localization of Wee1 as FLNA suppression in the M2
cell leaded to a diffusion of Wee1 to the cytoplasm (Fig. 8h). Furthermore, Wee1 expression
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levels were higher in unsynchronized FlnAy/- cells (Fig. 8i, left two bands), and Wee1
degradation was slower in nocodazole-synchronized FlnAy/- cells as progenitors advanced
through mitosis (Fig. 8i, right lanes). Our results suggested that FlnA regulated Wee1
stability and expression levels and thereby directed cdk1 phosphorylation and inactivation.
DISCUSSION
FlnA interactions with trans-membrane receptors and actin provide for a variety of signaling
pathways with which to regulate neural progenitor proliferation. For example, FlnA binds
integrin β1, which is a cell adhesion receptor for extracellular matrix proteins like laminin,
fibronectin and collagen (Loo et al., 1998). FlnA shares some common functional
characteristics with integrins (Schwartz and Assoian, 2001; Aszodi et al., 2003; LaFlamme
et al., 2008): (1) both promote proliferation through regulating cell cycle progression,
particularly in M phase and in G1 phase; (2) they promote progenitor differentiation; and (3)
they both regulate focal adhesion formation and stress fiber maturation (our unpublished
observation). In this respect, FlnA might serve as a key bridge in the signal transduction
between integrin and downstream molecules. Our current studies provided a possible
signaling pathway, whereby integrin could regulate M phase progression. Integrin has been
found to influence cytokinesis in chondrocytes. FlnA has also been reported to regulate
cytokinesis during cell division (Playford et al., 2006), and our immunostaining for FlnA
suggested that the protein was concentrated near the cleavage furrow and at the midbody
(unpublished data). Alternatively, both FlnA and integrin have been implicated in G1 phase
progression. FlnA has been reported to bind several downstream molecules of the ERK-
MAPK pathway, such as Ras GTPase and MKK4 (Ohta et al., 1999; Sarkisian et al., 2006),
and integrin has been found to promote G1 phase progression via the ERK pathway
(Schwartz and Assoian, 2001; Aszodi et al., 2003). Thus, FlnA might also regulate G1 phase
progression via the potential integrin-ERK pathway. Finally, FlnA binds and interacts with
F-actin, and F-actin has also been reported to promote cell proliferation by regulating G1
phase progression (Huang et al., 2002). Interestingly, we do see a significant decrease in F-
actin staining in the FlnA-null E18 brain (unpublished observation) and this loss would
potentially influence G1 phase progression even if secondarily. Overall, the filamin family
of actin binding proteins likely plays a complex regulatory role in maintenance and
stabilization of various proteins involved in cell cycle regulation.
FlnA regulation of cyclinb1 degradation is a key factor for progression through mitosis once
a cell enters metaphase. Our study found that the rate of cyclinb1 degradation in FlnA-null
progenitors was significantly reduced, which could explain the delayed mitotic progression
of FlnA-null progenitors. Prior studies have reported physical binding of FlnA to cyclinb1,
leading to FlnA phosphorylation by cyclinb1-activated kinase cdk1 and the ability of FlnA
to cross-link actin (Cukier et al., 2007). We did find that FlnA was highly phosphorylated in
neural progenitors during G2/M phase, but were unable to confirm endogenous interactions
between FlnA and cyclinb1 via bi-directional co-immunoprecipitation. Differences of
sequence and structure between mouse FlnA and human FLNA may be in part responsible
for this discrepancy. Alternatively, the prior work's findings may reflect non-physiologic
interactions given the tendency for non-specific binding of the filamins and the reliance on
over-expression of FLNA or cyclinb1 to demonstrate a physical interaction. Whether direct
or indirect, both studies would suggest some shared role between FlnA and cyclinb1.
Various components in the APC system can regulate cyclinb1 degradation (Visintin et al.,
1997). We found that the expression levels of both cdc20 and cdh1 (APC regulators that
promote progression through metaphase to anaphase and anaphase to G1 as well as cyclinb1
degradation) in null FlnA progenitors were not decreased but increased, and their
degradation rates were also slower, similar to that of cyclinb1. This observation suggested
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that a primary activation defect in the APC system might collectively lead to the slower
degradation of cyclinb1, cdc20 and cdh1. Previous reports have demonstrated that
phosphorylation of APC subunits by activated cdk1 or pilk1 leads to activation of the APC
system (Rudner and Murray, 2000; Golan et al., 2002). Moreover, phosphorylation of cdk1
at amino acid sites theronine-14 and tyrosine-15 inactivates cdk1 (Gould and Nurse, 1989;
Atherton-Fessler et al., 1993). We found that loss of FlnA promoted cdk1 phosphorylation
on tyrosine-15 in neural progenitors and that phosphorylation levels remained elevated
throughout mitosis, suggesting that cdk1 activity was inhibited throughout the mitotic cycle.
We interpreted these findings to indicate that the delayed degradation of cyclinb1 seen after
loss of FlnA and during mitosis was linked to a primary dysregulation of cdk1
phosphorylation.
Wee1-like family kinases, like Wee1 and Pkymt1, can phosphorylate cdk1 on tyrosine-15,
whereas cdc25c family phosphatases with its partner protein 14-3-3 can dephosphorylate
cdk1 at this site. Recently, FLNA was also reported to regulate entry into mitosis through
cdc25c participation (Telles et al.). We could not identify any significant binding between
FLNA and cdc25c. The difference in results from those reported likely is due to the fact that
the prior work used either GST or over-expression studies through transfection to
demonstrate binding between these two proteins. Additionally, we did not find any change
in neural progenitor expression levels of cdc25c or 14-3-3 after FlnA suppression. We did,
however, identify a weak interaction between FlnA and 14-3-3, suggesting that this pathway
might still contribute to and promote entry into mitosis. More prominently, the expression of
Wee1-like kinases in FlnA-null progenitors was increased compared to that in FlnA-WT
progenitors. Our findings that FlnA endogenously co-immunoprecipitated with Wee1
indicated that FlnA likely regulates the levels of Wee1 protein in neural progenitors and this
pathway led to the increased phosphorylation of cdk1 in FlnA-null progenitors. Given that
Wee1 and Pkymt1 share similar proline rich domains and are expressed in neural
progenitors, it is likely that Pkymt1 will be capable of binding FlnA. One possibility might
be that FlnA regulates the degradation of these proteins through the ubiquitination system,
given APC's role as an E3 ubiquitin ligase and FlnA interactions with members of the Skp,
Cullin, F-box containing complex (SCF) pathway (unpublished observations). Further
clarification of how FlnA regulates either Wee1 or Pkymt1 will need investigation.
The current studies demonstrate that loss of FlnA in mice does not lead to PH formation in
the lateral ventricles of mice but rather a reduction in brain size. The mild microcephaly
seen in the mice mirrors the human phenotype in males that harbor mutations in FLNA. The
female heterozygous FlnA mice show a mild reduction in brain size but no heterotopia
formation in the lateral ventricles. There has been a prior report of nodular formation in the
third ventricles of null FlnA mice, although this appears to be an inconsistent finding
(Adams et al., 2012). We observe a thinning in the neuroependymal lining of null FlnA mice
but no PH formation (unpublished observations). The absence of PH may reflect the fact that
the mice are late embryonic lethal and heterotopia formation may not yet have occurred at
this stage of development. Alternatively, we have previously shown that disruption of the
neuroependymal lining can lead to nodular heterotopia with loss of BIG2, the second gene
mutation in humans that causes PH (unpublished observations and Ferland et al., 2009). In
this context, it is possible that the mechanical stressors in the human neuroepithlium may be
greater than that in the mouse and that loss of FlnA function alone is not sufficient to cause
PH formation in mice. Finally, the observed microcephaly and thinning of the
neuroependyma with loss of FlnA may extend from a common role for filamins in
regulation of vesicle trafficking and therefore the turnover of cell surface and intracellular
proteins. For example, loss of cell surface adhesion proteins such as integrins and cadherins
would likely lead to weakening of the neuroependyma and disrupt progenitor proliferation
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through integrin-mediated cyclin activity. Additional studies will be required to understand
this possible relationship.
While our findings demonstrate a novel role for actin-binding proteins in regulating the
degradation of cell cycle-related proteins in the brain and giving rise to microcephaly, loss
of FlnA function also influences the development of various other organ systems. FlnA
appears to be involved in blood vessel and heart formation given the vasculopathy and
valvular defects seen in the null mice. Suppression of this actin-binding protein also leads to
midline closure defects involving the sternum and palate, suggesting a defect in skeletal
formation. Additionally, development of omphalocele and observed shortening of the gut
similarly implies a disruption in gastrointestinal development. Lastly, the null FlnA mouse
exhibits an overall reduction in body size. Taken in total, these observations raise the
possibility that FlnA function as it relates to cell cycle regulation of the neural progenitor
pool may extend more broadly to other progenitors across various tissue and organ systems
and thereby provide a general mechanism of function and action.
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Figure 1. FlnA-/- mice display mild microcephaly, omphalocele formation, and an overall
reduction in body size
(a) E18 FlnAy/- whole embryo with a smaller body size and a midline closure defect with
omphalocele when compared to littermate FlnAy/+ embryos. (b) A reduction in brain size
and disruption of the vasculature can also be appreciated in the null FlnA brain. (c)
Photomicrographs of hematoxylin and eosin (H&E) stained coronal sections from various
aged embryonic mouse brains show a reduction in cortical width in the FlnAy/-
telencephalon as compared to littermate control. (d) Higher magnification of the outlined
area in (c) shows that the greatest differences in thickness are observed in the cortical plate.
Quantification with statistical analysis is graphically shown below with the thickness of
FlnAy/- cortices reduced 9% and 15%, respectively, at E15.5 and E18 when compared to
FlnAy/+ littermate controls (n>3). (e) Fluorescent photomicrographs of cortex following
FlnA immunohistochemisty on paraffin-embeded E15.5 brain sections show that FlnA
(fluoroscein fluorescence) is highly expressed in the ventricular and subventricular zones,
primarily along the apical surface of the ventricles (arrow head). In contrast, no FlnA
staining is seen in FlnAy/- cortex. Sections are counterstained with the Hoechst nuclear
marker (DAPI). MZ, margin zone; CP, cortical plate; SP, subplate; IZ, intermediate zone;
SVZ, subventricular zone and VZ, ventricular zone, scale bar: 100μm; **= p < 0.01, *= p <
0.05.
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Figure 2. Reduction in the neural progenitor population with loss of FlnA function at embryonic
day 18
(a) Fluorescent photomicrographs of both E18 FlnAy/- and FlnAy/+ cortex after
immunostaining for proliferation and apoptotic markers: Ki-67, a marker for cells in the cell
cycle; phospho-histone H3 (PH3), a M-phase marker; BrdU, a marker labeling cells entering
into S-phase; and TUNEL staining, a marker for programmed cell death. Pregnant mice at
E17 received a single injection of BrdU (100 mg/kg, intraperitoneal) and sacrificed 24 hours
later. Frozen sections were cut at 12 microns and immunostained for expression of Ki-67
(fluoroscein), PH3 (fluoroscein), BrdU (rhodamine) and apoptotic cells (rhodamine). Scale
bar: 100μm. (b) Higher magnification photomicrographs of the images in (A) demonstrate
the reduction in the number of cells labeled by the various proliferative markers in the FlnA
mutant mice. (c) Statistical analyses (n≥3 independent samples per experiment) showed that
the numbers of cells per unit area positively labeled for Ki-67, PH3 and BrdU in FlnAy/-
cortex were decreased by 28.2%, 25% and 31%, respectively when compared to littermate
controls. No significant increase in TUNEL staining was seen in the FlnAy/- cortices. ***= p
<0.001.
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Figure 3. Early decline in the neural progenitor population in E15.5 FlnAy/- cortex
(a) E15.5 FlnAy/- embryos exhibited a similar decrease (albeit less significant) in the
number of proliferating progenitors by Ki-67, PH3 and BrdU labeling. E14.5 pregnant mice
were pulse-labeled with BrdU for 24 hours. Immunostaining was performed with anti-Ki-67
(proliferative marker), PH3 (M-phase marker) and/or BrdU (S-phase marker) and positively
stained cells were visualized under fluorescent microscopy and quantified by comparison
between serial, littermate FlnAy/+ and FlnAy/- cortical sections. Scale bar: 100μm. (b)
Higher magnification photomicrographs of the images in (a) demonstrated the reduction in
the number of cells labeled by the various proliferative markers in the FlnA mutant mice.
Scale bar: 50μm. (c) Quantification of the staining and statistical results were shown for n=3
samples per variable. *= p < 0.05.
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Figure 4. Diminished brain size in null FlnA mice is not due to an increase in neural
differentiation
(a) Relative rates of proliferation and differentiation of neural progenitors destined for both
upper and lower cortical layers (corresponding to earlier and later born neurons,
respectively) were identified after immunostaining of E18 brain sections with reelin and
chondroitin sulfate proteoglycan (CSPG). Reelin served as a marker for the superficial
marginal zone (molecular layer), whereas CSPG labeled both subplate and intermediate
zone neurons. Staining for either of these markers was reduced or unchanged in the FlnAy/-
cortex, suggesting no increase in early differentiation. (b) Immunostaining for Tbr-2
(fluoroscein, above), a differentiating progenitor marker, and Tbr-1 (fluoroscein, below), an
earlier born neuronal marker, indicates a decrease in the width of the cortical layers and
therefore decreases in the number of earlier born neurons in the FlnAy/- cortex compared to
WT. Co-staining for Ki-67 (fluoroscein) and BrdU (rhodamine) demonstrated an increase of
approximately 3% in the relative number of proliferating progenitors in the FlnAy/- brain,
consistent with a decreased rate of differentiation. Scale bar: 100μm. (c) Higher
magnification photomicrographs of the images in b demonstrated the reduction in the
staining of the various differentiation markers. Scale bar: 50μm. (d) Quantification of the
images is shown below. Statistical analyses were performed on serial sections from n>3
brains per experimental variable and demonstrated a decrease in labeled cells per unit area
(relative to the number of Sox2 positive cells) by 5.5% and 4.2%, respectively, for Tbr-1and
Tbr-2. The number of Sox2 progenitors was also decreased by approximately 10% in the
FlnAy/- cortex compared to control. Sections were counterstained with nuclear Hoechst
(DAPI). MZ, marginal zone; CP, cortical plate; SP, subplate; IZ, intermediate zone; SVZ,
subventricular zone and VZ, ventricular zone. *= p < 0.05, *** = p< 0.001.
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Figure 5. FlnA loss causes a prolongation of cell cycle length in vivo
(a) Cumulative BrdU labeling estimates the time required for neural progenitors in the VZ to
complete each phase of the cell cycle. With loss of FlnA function, fewer progenitors
incorporated BrdU at 3 and 9h, consistent with an overall prolongation of the cell cycle. By
14h, virtually all VZ progenitors were labeled in both mutant and WT mice. (b) Co-staining
for PH3 at various times after BrdU labeling enabled determination of the time required to
complete G2 to M-phase (TG2+M when all PH3+ cells were BrdU positive). Mitotic BrdU
labeling indexes were calculated from the proportion of Brdu+ and PH3+ nuclei to total
PH3+ nuclei along the ventricular surface. The ratio of M-phase cells to the total cells in
ventricular zone was measured by direct cell count. (c) The labeling index, obtained from
the cumulative BrdU experiments, allowed for determination of the entire cell cycle length
(Tc), as well as time required to complete S-phase (Ts). Time to complete M-phase (TM) was
estimated by taking the ratio of cells along the ventricular lining, as compared to the total
number of progenitors within the VZ. V= ventricle, VZ= ventricular zone, SVZ=
subventricular zone and CP= cortical plate. Based on the labeling index at each time
interval, BrdU labeling curves for FlnAy/+ (■) and FlnAy/- (▲) neural progenitors were
developed by linear fit (the panel at right bottom). *= p < 0.05.
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Figure 6. FlnA regulates cell cycle progression from G2 to M phase
(a) FlnAy/- progenitors underwent a slower rate of growth as visualized with phase contrast
microscopy. Neural progenitors from E13.5 brain cortex were plated on laminin-coated
dishes at a cell density of 5×104 cells/cm2. FlnAy/+ progenitor cells grew to confluency
within 30 h post-plating, whereas FlnAy/- progenitor cells achieved only 70-80% confluency
during the same time interval and under the same culture conditions. (b) Quantification to
the right indicates a 25% decrease in the proliferation rate for FlnAy/- neural progenitors
when compared to progenitors isolated from littermate controls (Scale bar: 50μm; n≥3
independent samples per variable, ***= p <0.001). (c) Flow cytometric analyses
demonstrated a faster cell cycle progression from S to G1 phase in FlnAy/+progenitors. The
cell cycle of BrdU-labeled progenitors progresses from S to G1 phase (arrowheads) for
varied culture time post BrdU pulse. Cultured progenitor cells were pulse-labeled with BrdU
for 40 min and fixed at various time points post-pulse. The fixed cells were stained with
anti-BrdU antibody and 7-AAD, a fluorescent dye for DNA. (d) Flow cytometric analyses
showed that FlnAy/+progenitors underwent a faster cell cycle progression from G2/M
(second unlabeled peak to the right) to G1 (arrowheads) phase. Cultured neural progenitors
were synchronized to G2/M phase by nocodazole treatment, and then released from
nocodazole to allow cycle progression. The cells were harvested at various time points and
stained with propidium iodide (PI). Sample flow cytometry results were shown for n>3
replicates (P value <0.001).
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Figure 7. FlnA impairs cyclin B degradation and inhibits cdk1 phosphorylation
(a) Expression of cyclinb1 and cyclinb1-associated proteins was prolonged in FlnAy/-
progenitors during the transition from G2/M to G1. In FlnAy/+ cells, protein levels of
cyclinb1, cdh1 and cdc20 gradually declined as cells progressed through M-phase. The
decline of these protein levels in FlnAy/- cells was much slower. As a downstream target of
cdk1/cyclinb1, PH3 levels also decreased albeit at a slower rate in the FlnAy/- progenitors.
(b) Delayed degradation of cyclinb1 and cyclinb1-associated proteins in FlnAy/- progenitors.
Cultured neural progenitors were treated with cycloheximide to block protein synthesis.
Cyclinb1 and cdc20 in FlnAy/+ progenitors underwent gradual degradation over a period of
240 min, but their degradation rates were significantly delayed in FlnAy/- progenitors. (c)
Levels of phosphorylated cdk1 (Tyr15) in null FlnA neural progenitors and M2 melanoma
cells were increased compared to controls by western blot analyses. The levels of cdc20 and
cdh1 were increased in FlnAy/- neural progenitors but unchanged in FLNA-null M2
melanoma cells. Noticeably, total cdk1 expression levels were decreased but cdk1
phosphorylation (Tyr15) levels were significantly increased by 3 fold in both FlnA-null
progenitor and melanoma cell lines. (d) The high levels of phospho-cdk1 were maintained
for the entirety of the M- phase in FlnAy/- neural progenitors, as evidenced by western blot.
Quantitative plots are shown to the right. The values reflect the mean +/- standard deviation
from 3 separate experiments (***= p < 0.001, **= p < 0.01, *=p <0.05).
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Figure 8. FlnA interacts with Wee1 to promote entry into M phase
(a) FlnA did not physically interact endogenously with cyclinb1. Western blot analysis was
performed using WT neural progenitors synchronized by nocodazole treatment. Cdk1 was
strongly co-immunoprecipitated by cyclinb1, but FlnA was not. (b) Cdc25c did not show a
strong physical interaction with FLNA. Although FLNA is immunoprecipitated from the
homogenized solution of nocodazole treated A7 melanoma cells, cdc25c is not detected
from the pull-down. (c) FlnA weakly binds to 14-3-3 protein by western blot analyses. (d)
Western blot analysis shows that FlnA significantly interacts with Wee1 by endogenous co-
immunoprecipitation using anti-Wee1 antibody and neural progenitor homogenized lysate.
(e) The same physical binding was observed using FLNA expressing A7 melanoma cells. (f)
Wee1 was pulled down by purified GST-FLNA-C terminal recombinant protein from A7
cell lyses. (g) Fluorescent photomicrographs demonstrated FLNA (fluoroscein) overlapping
expression with Wee1 (rhodamine) at the cell membrane and peri-nuclear region of A7
melanoma cells. (h) Fluorescent photomicrographs showed Wee1 (rhodamine) expression
within the Golgi (GM130 Golgi marker, arrow) and cell membrane (arrow) in FLNA-replete
A7 cells. In the absence of FLNA (M2 cell line), Wee1 became more diffusely localized
throughout the cytoplasm and membrane (arrows). (i) Degradation of Wee1 was also
impaired in FlnAy/- progenitors. Cells were nocodazole synchronized and expression levels
of Wee1 protein were greater in the FlnAy/- cells compared to controls, at all time points
sampled. All the assays involving Wee1 co-immunoprecipitation were confirmed with at
least 3 replicates. Scale bar: 10μm.
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